01 1Yacht Bio-Technology
01 1DAPTOMYCIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-11-28
Pay. Date : 2018-09-25
DMF Number : 33004
Submission : 2018-08-08
Status : Active
Type : II
20
Chengdu Yacht Biotechnology Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is DAPTOMYCIN, with a corresponding US DMF Number 33004.
Remarkably, this DMF maintains an Active status since its submission on August 08, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 28, 2018, and payment made on September 25, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
